Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36756387)

  • 21. Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice.
    Walker GV; Gilbert MR; Prabhu SS; Brown PD; McAleer MF
    J Neurooncol; 2013 Mar; 112(1):83-9. PubMed ID: 23266723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary cerebral gliosarcoma: about two cases and review of the literature].
    Azami MA; Alami IE; Bourhafour I; Belhabib S; Oukabli M; Albouzidi A
    Pan Afr Med J; 2017; 27():14. PubMed ID: 28904651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
    Sreenan JJ; Prayson RA
    Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
    Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
    J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric gliosarcoma treated with adjuvant radiotherapy and temozolomide.
    Mallick S; Gandhi AK; Sharma DN; Gupta S; Haresh KP; Rath GK; Julka PK
    Childs Nerv Syst; 2015 Dec; 31(12):2341-4. PubMed ID: 26438548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gliosarcoma with osteosarcomatous features: a short illustrated review.
    Charfi S; Ayadi L; Khabir A; Daoud E; Kallel R; Kharrat O; Mnif Z; Boudawara Z; Makni S; Boudawara T
    Acta Neurochir (Wien); 2009 Jul; 151(7):809-13; discussion 813. PubMed ID: 19399365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up results of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastoma multiforme patients. The importance of MRI information in survival: Single-center experience.
    Lukács G; Tóth Z; Sipos D; Csima M; Hadjiev J; Bajzik G; Cselik Z; Semjén D; Repa I; Kovács Á
    Ideggyogy Sz; 2018 Mar; 71(3-04):95-103. PubMed ID: 29889468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological characteristics and outcomes of Gliosarcoma.
    Hashmi FA; Salim A; Shamim MS; Bari ME
    J Pak Med Assoc; 2018 Aug; 68(8):1273-1275. PubMed ID: 30108403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pediatric Gliosarcoma: Case Report and Literature Review].
    Moscote-Salazara LR; Alcalá-Cerra G; Gutiérez-Paternina JJ; Penagos Gonzélezc PJ; Zubieta Vega C; Chater-Cure G; Alberto Meneses C; Saenz M
    Bol Asoc Med P R; 2014; 106(3):43-7. PubMed ID: 25470910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastoma.
    Pierscianek D; Ahmadipour Y; Michel A; Rauschenbach L; Darkwah Oppong M; Deuschl C; Kebir S; Wrede KH; Glas M; Stuschke M; Sure U; Jabbarli R
    Clin Neurol Neurosurg; 2021 Jan; 200():106348. PubMed ID: 33158630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics and outcomes for a modern series of primary gliosarcoma patients.
    Han SJ; Yang I; Ahn BJ; Otero JJ; Tihan T; McDermott MW; Berger MS; Prados MD; Parsa AT
    Cancer; 2010 Mar; 116(5):1358-66. PubMed ID: 20052717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Postoperative radiotherapy of glioblastoma multiforme: analysis and critical assessment of different treatment strategies and predictive factors.
    Piroth MD; Gagel B; Pinkawa M; Stanzel S; Asadpour B; Eble MJ
    Strahlenther Onkol; 2007 Dec; 183(12):695-702. PubMed ID: 18040615
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma.
    Lewitzki V; Klement RJ; Kosmala R; Lisowski D; Flentje M; Polat B
    Radiat Oncol; 2019 Dec; 14(1):227. PubMed ID: 31831026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic and genomic features of gliosarcomas.
    Lee D; Kang SY; Suh YL; Jeong JY; Lee JI; Nam DH
    J Neurooncol; 2012 May; 107(3):643-50. PubMed ID: 22270848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors among single primary gliosarcoma cases: A study using Surveillance, Epidemiology, and End Results data from 1973-2013.
    Chen B; Liu B; Wu C; Wang Z
    Cancer Med; 2019 Oct; 8(14):6233-6242. PubMed ID: 31464103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective comparison of standard and escalated doses of radiotherapy in newly diagnosed glioblastoma patients treated with concurrent and adjuvant temozolomide.
    Guler OC; Yıldırım BA; Önal C; Topkan E
    Indian J Cancer; 2019; 56(1):59-64. PubMed ID: 30950447
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gliosarcomas in the elderly: analysis of 7 cases and clinico-pathological remarks.
    di Norcia V; Piccirilli M; Giangaspero F; Salvati M
    Tumori; 2008; 94(4):493-6. PubMed ID: 18822684
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extent of surgical resection and adjuvant temozolomide improves survival in pediatric GBM: a single center experience.
    Gupta S; Mallick S; Benson R; Haresh KP; Julka PK; Rath GK
    Childs Nerv Syst; 2017 Jun; 33(6):951-956. PubMed ID: 28424876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
    Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
    Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.